


Ask a doctor about a prescription for FESOTERODINE ALTER 4 mg PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the Patient
Fesoterodina Alter 4 mg prolonged-release tablets EFG
Fesoterodina Alter 8 mg prolonged-release tablets EFG
Fesoterodina, fumarate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
This medicine contains the active substance fesoterodine fumarate and is a treatment called an antimuscarinic, which reduces the activity of the overactive bladder and is used in adults to treat the symptoms.
Fesoterodina treats the symptoms of an overactive bladder, such as:
Do not take Fesoterodina Alter
Warnings and precautions
Consult your doctor or pharmacist before starting to take Fesoterodina Alter.
Fesoterodina may not always be suitable for you. Talk to your doctor before taking fesoterodine in any of the following cases:
Heart problems: Inform your doctor if you have any of the following conditions:
Children and adolescents
Do not give this medicine to children and adolescents under 18 years of age because it has not been established whether it works and is safe for them.
Other medicines and Fesoterodina Alter
Tell your doctor or pharmacist if you are taking or have recently taken or may need to take any other medicines. Your doctor will tell you if you can use fesoterodine with other medicines.
Please inform your doctor if you are taking medicines from the list below. Taking these medicines at the same time as fesoterodine may cause side effects such as dry mouth, constipation, difficulty emptying the bladder completely or more severe or frequent drowsiness than usual.
Please indicate to your doctor if you are taking any of the following medicines:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take fesoterodine if you are pregnant, as the effects of fesoterodine on pregnancy and the newborn are unknown.
It is unknown whether fesoterodine is excreted in breast milk; therefore, do not breastfeed during treatment with this medicine.
Driving and using machines
Fesoterodina may cause blurred vision, dizziness and drowsiness. If you experience any of these effects, do not drive or operate tools or machines.
Fesoterodina Alter contains fructose and lactose
If your doctor has told you that you (or your child) have an intolerance to certain sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which the patient cannot break down fructose, consult your doctor before taking this medicine.
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended initial dose is one 4 mg fesoterodine tablet per day. Depending on how you respond to the medicine, your doctor may prescribe a higher dose; one 8 mg fesoterodine tablet per day.
Swallow the tablet whole with a glass of water. Do not chew the tablet. This medicine can be taken with or without food.
To help you remember to take your medicine, it may be easier to take it at the same time every day.
If you take more Fesoterodina Alter than you should
If you have taken more tablets than you should or if someone else has taken your tablets by mistake, contact your doctor or hospital immediately. Show them the package of the tablets.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Fesoterodina Alter
If you have forgotten to take a tablet, take it as soon as you remember, but do not take more than one tablet in a day. Do not take a double dose to make up for forgotten doses.
If you stop taking Fesoterodina Alter
Do not stop taking fesoterodine without talking to your doctor first, as the symptoms of overactive bladder may return or worsen when you stop taking this medicine.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious
Other side effects
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging and on the blister, after “EXP”. The expiry date is the last day of the month stated.
Do not store above 25°C.
Store in the original packaging to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to a pharmacy for proper disposal. This will help protect the environment.
Composition of Fesoterodina Alter
Fesoterodina Alter 4 mg: Each prolonged-release tablet contains 4 mg of fesoterodine fumarate, equivalent to 3.1 mg of fesoterodine.
Fesoterodina Alter 8 mg: Each prolonged-release tablet contains 8 mg of fesoterodine fumarate, equivalent to 6.2 mg of fesoterodine.
Core of the tablet: fructose, lactose monohydrate-microcrystalline cellulose spheres, hypromellose, dibehenate of glycerol, talc.
Coating of the tablet: poly(vinyl alcohol), titanium dioxide (E171), macrogol, talc and carmine indigo (E132).
Appearance of the product and contents of the pack
Fesoterodina Alter 4 mg: film-coated tablets, 13.1 x 6.0 mm, blue, elliptical, biconvex, with the engraving “F4” on one side.
Fesoterodina Alter 8 mg: film-coated tablets, 13.1 x 6.0 mm, dark blue, elliptical, biconvex, with the engraving “F8” on one side.
Fesoterodina Alter is available in aluminum-aluminum blisters, in packs containing 28 tablets.
Marketing authorisation holder
Laboratorios Alter, S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
Manufacturer
Laboratorios Normon, S.A.
Ronda de Valdecarrizo 6
28760 Tres Cantos, Madrid
Spain
Or
Laboratorios Liconsa, S.A.
Avda. Miralcampo 7
Polígono Industrial Miralcampo
19200 Azuqueca de Henares, Guadalajara
Spain
Date of last revision of this leaflet
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.
The average price of FESOTERODINE ALTER 4 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 17.87 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for FESOTERODINE ALTER 4 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.